Implantation of a leadless transcatheter pacing system after interventional ventricular septal defect closure
- PMID: 34552850
- PMCID: PMC8441197
- DOI: 10.1016/j.hrcr.2021.05.019
Implantation of a leadless transcatheter pacing system after interventional ventricular septal defect closure
Keywords: Congenital heart disease; Leadless pacemaker; Micra TPS; VSD occluder; Ventricular septal defect.
Figures
References
-
- Kusumoto F.M., Schoenfeld M.H., Barrett C. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. Circulation. 2019;140:e333–e381. - PubMed
-
- Tjong F.V., Reddy V.Y. Permanent leadless cardiac pacemaker therapy: a comprehensive review. Circulation. 2017;135:1458–1470. - PubMed
-
- Reynolds D., Duray G.Z., Omar R. A leadless intracardiac transcatheter pacing system. N Engl J Med. 2016;374:533–541. - PubMed
-
- Russell M.R., Galloti R., Moore J.P. Initial experience with transcatheter pacemaker implantation for adults with congenital heart disease. J Cardiovasc Electrophysiol. 2019;30:1362–1366. - PubMed
-
- Garweg C., Vandenberk B., Foulon S. Leadless pacing with Micra TPS: a comparison between right ventricular outflow tract, mid-septal, and apical implant sites. J Cardiovasc Electrophysiol. 2019;30:2002–2011. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
